Furthermore, in clear cell renal cell carcinoma (ccRCC), MFN2 can inhibit the progression of ccRCC by blocking cellular lipid metabolism and reducing lipid droplet accumulation (Cai, et al. 2024). This evidence concerns the gene MFN2 and nonpapillary renal cell carcinoma.